PubMed Health⌕ Search

PubMed · 6193206

Acyclovir in herpes simplex keratitis.

Abstract

Herpes simplex keratitis is the most frequent cause of loss of vision from corneal disease in the industrialised world. This has led to the widespread use of a variety of antiviral drugs in treatment and these are reviewed, with particular attention to their clinical value. Study of the reports concerning the use of acyclovir (ACV) in this condition suggests that this antiviral may be more effective than others, not only in acute infections but possibly in herpetic iridocyclitis and also as a prophylactic antiviral cover following corneal grafting.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M G Falcon. 1983. Acyclovir in herpes simplex keratitis.. https://doi.org/10.1016/s0163-4453(83)94107-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Synthesis, DNA binding and antiviral activity of new uracil, xanthine, and pteridine derivatives.

Some new 6-amino-1,3-dimethyl-5-(substituted methylidene)aminouracils were synthesized. Most of them were cyclized with triethyl orthoformate as a one-carbon source to afford 1,3-dime-thyl-6-substituted pteridine derivatives. Certain uracils gave xanthine instead of the expected pteridine derivatives upon using another one-carbon source such as triethyl orthoacetate or triethyl orthobenzoate. The nucleic acid binding assay revealed that some new compounds showed high affinity, chelation, and fragmentation of nucleic acids whether DNA or RNA contrary to acyclovir that has affinity to DNA only. The antiviral activity of these novel compounds showed that compounds 2e and 2f reduced the cytopathogencity of Peste des petits ruminant virus (PPRV) on Vero cell culture by 60 and 50%, respectively.

Acyclovir↗